- Summary
- Table Of Content
- Methodology
Glucosamine Market Size :
Consegic Business Intelligence analyzes that the glucosamine market size is growing with a CAGR of 5.8% during the forecast period (2023-2030), and the market is projected to be valued at 1,082.65 Million by 2030 from 693.50 Million in 2022.
Glucosamine Market Scope & Overview:
Glucosamine is a natural sugar that is made up of amino acids and fructose found in cartilage. Glucosamine supplements are manufactured by harvesting glucosamine from shells of shellfi
Glucosamine Market Size :
Consegic Business Intelligence analyzes that the glucosamine market size is growing with a CAGR of 5.8% during the forecast period (2023-2030), and the market is projected to be valued at 1,082.65 Million by 2030 from 693.50 Million in 2022.
Glucosamine Market Scope & Overview:
Glucosamine is a natural sugar that is made up of amino acids and fructose found in cartilage. The supplements are manufactured by harvesting glucosamine from shells of shellfish or can be manufactured in laboratories. It plays a very important role in maintaining the health of joint tissues in the human body and it is often used as a dietary supplement to support joint health.
Moreover, based on the analysis, in the pharmaceutical sector, this compound is used for the manufacturing of drugs for the treatment of arthritic joint pain, glaucoma, weight loss, interstitial cystitis, a bladder condition, heart disease, and others. It is commonly available in the form of dietary supplements, including capsules, tablets, and liquid formulations.
Glucosamine Market Insights :
Glucosamine Market Dynamics - (DRO) :
Key Drivers :
Increasing use of supplements to improve bone & joint health is propelling the glucosamine market growth
Glucosamine is a natural chemical compound present in the human body. The production of this compound in the human body reduces with age, which leads to symptoms such as mild to moderate knee osteoarthritis, joint pains, diabetes, and others. It plays an important role in making glycosaminoglycans and glycoproteins, which are essential building blocks of many parts of your joints, including ligaments, tendons, cartilage, and synovial fluid. Owing to this, the compound is actively used as an essential dietary supplement for maintaining overall bone & joint health in humans. Based on the analysis, the increasing prevalence of bone related disorders across various countries worldwide is a prominent factor driving the global glucosamine market demand. For instance, according to the report by the Australian Bureau of Statistics, in March 2022, 12.5% of the population across Australia is found to be diagnosed with Arthritis, and 3.6% of the population with Osteoporosis. This high prevalence of bone-related disorders is leading to the increased demand for these supplements for the treatment of this disease, which in turn, is fuelling the market growth.
Growing consumer awareness regarding the benefits of dietary supplements
The growing emphasis on health and wellness among consumers worldwide is leading to the increased demand for nutritional as well as dietary supplements for overall well-being. Supplements are perceived as a convenient and accessible means to address various health concerns in the human body. Overall trends in the consumption of dietary supplements among consumers globally is benefiting the global glucosamine market trend. For instance, according to the report published by the National Institute of Health in June 2023, the U.S. sale of dietary supplements in 2020 accounted for USD 55.7 billion, which was USD 34.5 billion in 2019. Based on the analysis, significant trend in the sale of dietary supplements across the U.S. is increasing the demand for this compound for maintaining overall bone health. The geriatric population is the largest population segment diagnosed with bone-related disorders. This increasing number of geriatric populations along with the growing trend of fitness and sports is also driving the trend of this compound worldwide.
Key Restraints :
Side effects is likely to deter market growth
The global demand for this compound as an effective supplement for the treatment of bone-related disorders is increasing. However, the consumption of this compound in some humans can lead to various side effects such as indigestion, constipation, diarrhea, headaches, rashes, and others. These side effects can range from mild to severe depending upon the resistance and acceptance capacity of person to person. People diagnosed with diseases such as diabetes, asthma, allergies, blood circulation issues, and others must be more aware of consuming this compound in the form of supplements. According to a report by the National Institute of Health, the compound enhances body weight gain and reduces insulin response. Another study found that the consumption of this compound might affect the glucose levels in the body, which makes it unsuitable for people with diabetes or glucose intolerance. Therefore, the aforementioned factors are anticipating the glucosamine market trend.
Future Opportunities :
The increasing prevalence of cancer is likely to accelerate market expansion
The compound possesses properties such as anti-cancer and anti-inflammatory benefits, due to which it plays a significant role in decreasing death rates from various types of cancers such as breast cancer, prostate cancer, colorectal cancer, and lung cancer. It shows anti-tumor effects and progresses the effects of apoptosis in the human body, by inducing autophagic death of cancer cells, reversing tumor drug resistance, anti-tumor angiogenesis, and inhibiting the expression of matrix metalloproteinases. Studies have shown that supplementation of this compound can lower the risk of lung cancer by 16%, 32% lower risk of kidney cancer mortality, 5% lower risk of overall cancer mortality, and 24% lower risk of rectum cancer mortality. Hence, the increasing prevalence of cancer across the globe is expected to provide lucrative global glucosamine market opportunities over the estimated period. For instance, according to the report by the American Cancer Society in January 2023, lung cancer accounted for the second most common cancer. Thus, based on the analysis, this high prevalence of cancer and cancer-related deaths and the potential application of this compound in reducing the mortality rate of cancer is likely to drive the market trends and opportunities over the forecast period.
Global Glucosamine Market Report Insights :
| Report Attributes | Report Details |
| Study Timeline | 2017-2030 |
| Market Size in 2030 | USD 1,082.65 Million |
| CAGR (2023-2030) | 5.8% |
| By Product Type | Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, and Others |
| By Form | Tablets, Powder, Liquid, and Others |
| By End-use Industry | Pharmaceuticals, Nutritional Supplements, Food & Beverages, Dairy, and Others |
| By Region | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
| Key Players | Nutralife Health Products Inc., Blackmores Ltd., Foodchem International Corporation, Health World Ltd., Glanbia plc., Cargill, Inc., Schiff Nutrition International, Inc., CAPTEK Softgel International Inc., Spectrum Chemicals, and Golden-Shell Pharmaceutical |
| Geographies Covered | |
| North America | U.S. Canada Mexico |
| Europe | U.K. Germany France Spain Italy Russia Benelux Rest of Europe |
| APAC | China South Korea Japan India Australia ASEAN Rest of Asia-Pacific |
| Middle East and Africa | GCC Turkey South Africa Rest of MEA |
| LATAM | Brazil Argentina Chile Rest of LATAM |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Restraint or Challenges, Opportunities, Environment & Regulatory Landscape, PESTLE Analysis, PORTER Analysis, Key Technology Landscape, Value Chain Analysis, Cost Analysis, and Regional Trends & Forecast |
Glucosamine Market Segmental Analysis :
By Product Type :
The product type segment is categorized into glucosamine sulfate, glucosamine hydrochloride, n-acetyl glucosamine, and others. In 2022, the glucosamine hydrochloride segment accounted for the highest market share in the overall glucosamine market. Glucosamine hydrochloride is a type of glucosamine supplement that is free from the sulfate group, and it is used for the treatment of rheumatoid arthritis, back pain, joint pain, heart diseases, strokes, and back pain. These symptoms can easily be seen in the elderly population. As per the analysis, the rising prevalence of heart diseases and strokes worldwide is driving the segment's trends globally. For instance, according to the report by the World Health Organization in June 2021, out of 17.9 million deaths due to cardiovascular diseases worldwide, 85% were due to heart attack and stroke.
However, the glucosamine sulfate segment is expected to grow at the fastest CAGR in the market during the forecast period. The trends of the segment is attributed to the increasing need for glucosamine sulfate as an oral supplement for the management and treatment of osteoarthritis. Osteoarthritis, also known as degenerative joint disease (DJD), is the most common type of arthritis. This disease is more likely to develop as people age. Increasing use of glucosamine sulfate in the form of supplements for the treatment and management of osteoarthritis is driving the segment trends.
By Form :
The form segment is categorized into tablets, powder, liquid, and others. In 2022, the powder segment accounted for the highest glucosamine market share at 35.10%. The powder form of the compound is the largest used form of this compoud owing to its various benefits. Powder forms are relatively easy to consume, a person can take the required quantity of this powder by readily measuring it in scoops and mixing it with liquid such as milk, water or can be mixed with smoothies. Based on the analysis, unlike other forms of this compound, which are tablets and capsules which need to be broken down and then digested and absorbed, powder form is easily absorbed in the human body. These high benefits of the powder form of this compound are driving the segment growth.
However, the tablets segment is expected to grow at the fastest CAGR in the overall glucosamine market. Tablets form of this compound is made by compressing powder form of this compound to form a hard pill, that can be either coated or non-coated and can take up to 20-30 minutes to absorb into the body. These forms are easy to store and transport and can hold more nutrients than other forms of this compound. As a result, the above-mentioned benefits are leading to an increased demand for the tablet form of this compound, which in turn, propels the market growth in the forecast years.
By End-Use-Industry :
The end-use industry segment is categorized into pharmaceuticals, nutritional supplements, food & beverages, dairy, and others. In 2022, the nutritional supplements segment accounted for the highest market share in the overall glucosamine market and is also expected to grow at the fastest CAGR in the market during the forecast period. Consumers become more aware of their healthy diets and healthy lifestyles across the globe. This growing awareness is increasing the demand for nutraceutical supplements for the treatment and management of various types of diseases. Consumers are more likely to experiment with health supplements and nutrition, which is a prominent factor influencing segment growth.
By Region :
The regional segment includes North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.
In 2022, North America accounted for the highest market share of 36.50% and was valued at USD 253.13 million and is expected to reach USD 397.87 million in 2030. In the North America region, the U.S. accounted for the highest market share of 68.75% during the base year 2022 owing to large key players of this compound along with increasing consumer spending on healthcare across the region. For instance, according to the report by the Centers for Medicare & Medicaid Services, in December 2022, U.S. healthcare spending grew 2.7% in 2021, reaching USD 4.3 trillion or USD 12,914 per person. Based on the glucosamine market analysis, this growing healthcare spending along with the presence of major key players in the region are the factors driving the glucosamine market in the North American region.
In addition, Asia Pacific is expected to grow at the fastest CAGR of 6.5% over the forecast period. The increasing geriatric population, growing consumer awareness regarding personal health, and significant growth in the pharmaceutical and nutraceutical industry are the factors expected to boost market growth across the region over the forecast period. For instance, according to the data published by International Trade Administration in September 2020, the nutraceuticals market in India is expected to grow from an estimated USD 4 billion to USD 18 billion by the end of 2025.
Top Key Players & Market Share Insights:
The glucosamine industry is highly competitive, with several large players and numerous small and medium-sized enterprises. These companies have strong research and development capabilities and a strong presence in the market through their extensive product portfolios and distribution networks. The market is characterized by intense competition, with companies focusing on expanding their product offerings and increasing their market share through mergers, acquisitions, and partnerships. The key players in the market include-
- Nutralife Health Products Inc.
- Blackmores Ltd.
- CAPTEK Softgel International Inc.
- Spectrum Chemicals
- Golden-Shell Pharmaceutical
- Foodchem International Corporation
- Health World Ltd.
- Glanbia plc.
- Cargill, Inc.
- Schiff Nutrition International, Inc.
Recent Industry Developments :
- In July 2023, Nestlé Purina PetCare, a manufacturer of pet food, announced the launch of a new supplement, targeting mobility in dogs. The new joint care supplement made up using glucosamine helps support mobility, healthy cartilage, and joints in dogs and puppies of all breeds and sizes.
- In October 2020, Nestle China announced the launch of a new milk powder in its functional foods product portfolio, which contains glucosamine for increasing bone density.
- In August 2020, JGL, a Croatia-based pharmaceutical company, announced the launch of a new food supplement Onaceron Forte for healthy joints. The product is based on glucosamine, which is used for normal cartilage and bone function.
Moreover, in the pharmaceutical industry glucosamine is used for the manufacturing of drugs for the treatment of arthritic joint pain, glaucoma, weight loss, interstitial cystitis, a bladder condition, heart disease, and others. It is commonly available in the form of dietary supplements, including capsules, tablets, and liquid formulations.
Glucosamine Market Insights :
Glucosamine Market Dynamics - (DRO) :
Key Drivers :
Increasing use of glucosamine supplements to improve bone & joint health is propelling the glucosamine market growth
Glucosamine is a natural chemical compound present in the human body. The production of glucosamine in the human body reduces with age, which leads to symptoms such as mild to moderate knee osteoarthritis, joint pains, diabetes, and others. Glucosamine plays an important role in making glycosaminoglycans and glycoproteins, which are essential building blocks of many parts of your joints, including ligaments, tendons, cartilage, and synovial fluid. Owing to this, glucosamine is actively used as an essential dietary supplement for maintaining overall bone & joint health in humans. The increasing prevalence of bone related disorders across various countries worldwide is a prominent factor driving the growth of the global glucosamine market. For instance, according to the report by the Australian Bureau of Statistics, in March 2022, 12.5% of the population across Australia is found to be diagnosed with Arthritis, and 3.6% of the population with Osteoporosis. This high prevalence of bone-related disorders is leading to the increased demand for glucosamine supplements for the treatment of this disease, which in turn, is fuelling the market growth.
Growing consumer awareness regarding the benefits of dietary supplements
The growing emphasis on health and wellness among consumers worldwide is leading to the increased demand for nutritional as well as dietary supplements for overall well-being. Supplements such as glucosamine are perceived as a convenient and accessible means to address various health concerns in the human body. Overall growth in the consumption of dietary supplements among consumers globally is benefiting the growth of the global glucosamine market. For instance, according to the report published by the National Institute of Health in June 2023, the U.S. sale of dietary supplements in 2020 accounted for USD 55.7 billion, which was USD 34.5 billion in 2019. The significant growth in the sale of dietary supplements across the U.S. is increasing the demand for glucosamine for maintaining overall bone health. The geriatric population is the largest population segment diagnosed with bone-related disorders. This increasing number of geriatric populations along with the growing trend of fitness and sports is also driving the growth of glucosamine worldwide.
Key Restraints :
Side effects associated with the use of glucosamine is likely to deter market growth
The global demand for glucosamine as an effective supplement for the treatment of bone-related disorders is increasing. However, the consumption of glucosamine in some humans can lead to various side effects such as indigestion, constipation, diarrhea, headaches, rashes, and others. These side effects can range from mild to severe depending upon the resistance and acceptance capacity of person to person. People diagnosed with diseases such as diabetes, asthma, allergies, blood circulation issues, and others must be more aware of consuming glucosamine in the form of supplements. According to a report by the National Institute of Health, glucosamine enhances body weight gain and reduces insulin response. Another study found that the consumption of glucosamine might affect the glucose levels in the body, which makes it unsuitable for people with diabetes or glucose intolerance. Therefore, the aforementioned factors are anticipating the glucosamine market growth.
Future Opportunities :
The increasing prevalence of cancer is likely to accelerate market growth
Glucosamine possesses properties such as anti-cancer and anti-inflammatory benefits, due to which it plays a significant role in decreasing death rates from various types of cancers such as breast cancer, prostate cancer, colorectal cancer, and lung cancer. It shows anti-tumor effects and progresses the effects of apoptosis in the human body, by inducing autophagic death of cancer cells, reversing tumor drug resistance, anti-tumor angiogenesis, and inhibiting the expression of matrix metalloproteinases. Studies have shown that glucosamine supplementation can lower the risk of lung cancer by 16%, 32% lower risk of kidney cancer mortality, 5% lower risk of overall cancer mortality, and 24% lower risk of rectum cancer mortality. Hence, the increasing prevalence of cancer across the globe is expected to provide lucrative glucosamine market opportunities over the estimated period. For instance, according to the report by the American Cancer Society in January 2023, lung cancer accounted for the second most common cancer. Thus, this high prevalence of cancer and cancer-related deaths and the potential application of glucosamine in reducing the mortality rate of cancer is likely to drive the market growth over the forecast period.
Global Glucosamine Market Report Insights :
| Report Attributes | Report Details |
| Study Timeline | 2017-2030 |
| Market Size in 2030 | USD 1,082.65 Million |
| CAGR (2023-2030) | 5.8% |
| By Product Type | Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, and Others |
| By Form | Tablets, Powder, Liquid, and Others |
| By End-use Industry | Pharmaceuticals, Nutritional Supplements, Food & Beverages, Dairy, and Others |
| By Region | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
| Key Players | Nutralife Health Products Inc., Blackmores Ltd., Foodchem International Corporation, Health World Ltd., Glanbia plc., Cargill, Inc., Schiff Nutrition International, Inc., CAPTEK Softgel International Inc., Spectrum Chemicals, and Golden-Shell Pharmaceutical |
| Geographies Covered | |
| North America | U.S. Canada Mexico |
| Europe | U.K. Germany France Spain Italy Russia Benelux Rest of Europe |
| APAC | China South Korea Japan India Australia ASEAN Rest of Asia-Pacific |
| Middle East and Africa | GCC Turkey South Africa Rest of MEA |
| LATAM | Brazil Argentina Chile Rest of LATAM |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Restraint or Challenges, Opportunities, Environment & Regulatory Landscape, PESTLE Analysis, PORTER Analysis, Key Technology Landscape, Value Chain Analysis, Cost Analysis, and Regional Trends & Forecast |
Glucosamine Market Segmental Analysis :
By Product Type :
The product type segment is categorized into glucosamine sulfate, glucosamine hydrochloride, n-acetyl glucosamine, and others. In 2022, the glucosamine hydrochloride segment accounted for the highest market share in the overall glucosamine market. Glucosamine hydrochloride is a type of glucosamine supplement that is free from the sulfate group, and it is used for the treatment of rheumatoid arthritis, back pain, joint pain, heart diseases, strokes, and back pain. These symptoms can easily be seen in the elderly population. The rising prevalence of heart diseases and strokes worldwide is driving the segment's growth globally. For instance, according to the report by the World Health Organization in June 2021, out of 17.9 million deaths due to cardiovascular diseases worldwide, 85% were due to heart attack and stroke.
However, the glucosamine sulfate segment is expected to grow at the fastest CAGR in the market during the forecast period. The growth of the segment is attributed to the increasing need for glucosamine sulfate as an oral supplement for the management and treatment of osteoarthritis. Osteoarthritis, also known as degenerative joint disease (DJD), is the most common type of arthritis. This disease is more likely to develop as people age. Increasing use of glucosamine sulfate in the form of supplements for the treatment and management of osteoarthritis is driving the segment growth.
By Form :
The form segment is categorized into tablets, powder, liquid, and others. In 2022, the powder segment accounted for the highest glucosamine market share at 35.10%. The powder form of glucosamine is the largest used form of glucosamine owing to its various benefits. Powder forms are relatively easy to consume, a person can take the required quantity of glucosamine powder by readily measuring it in scoops and mixing it with liquid such as milk, water or can be mixed with smoothies. Unlike other forms of glucosamine, which are tablets and capsules which need to be broken down and then digested and absorbed, powder form is easily absorbed in the human body. These high benefits of the powder form of glucosamine are driving the segment growth.
However, the tablets segment is expected to grow at the fastest CAGR in the overall glucosamine market. Tablets form of glucosamine made by compressing powder form of glucosamine to form a hard pill, that can be either coated or non-coated and can take up to 20-30 minutes to absorb into the body. These forms are easy to store and transport and can hold more nutrients than other forms of glucosamine. As a result, the above-mentioned benefits are leading to an increased demand for the tablet form of glucosamine, which in turn, propels the market growth in the forecast years.
By End-Use-Industry :
The end-use industry segment is categorized into pharmaceuticals, nutritional supplements, food & beverages, dairy, and others. In 2022, the nutritional supplements segment accounted for the highest market share in the overall glucosamine market and is also expected to grow at the fastest CAGR in the market during the forecast period. Consumers become more aware of their healthy diets and healthy lifestyles across the globe. This growing awareness is increasing the demand for nutraceutical supplements for the treatment and management of various types of diseases. Consumers are more likely to experiment with health supplements and nutrition, which is a prominent factor influencing glucosamine market trends.
By Region :
The regional segment includes North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
In 2022, North America accounted for the highest market share of 36.50% and was valued at USD 253.13 million and is expected to reach USD 397.87 million in 2030. In the North America region, the U.S. accounted for the highest market share of 68.75% during the base year 2022 owing to large key players of glucosamine along with increasing consumer spending on healthcare across the region. For instance, according to the report by the Centers for Medicare & Medicaid Services, in December 2022, U.S. healthcare spending grew 2.7% in 2021, reaching USD 4.3 trillion or USD 12,914 per person. This growing healthcare spending along with the presence of major key players in the region are the factors driving the market for glucosamine in the North American region.
In addition, Asia Pacific is expected to grow at the fastest CAGR of 6.5% over the forecast period. The increasing geriatric population, growing consumer awareness regarding personal health, and significant growth in the pharmaceutical and nutraceutical industry are the factors expected to boost market growth across the region over the forecast period. For instance, according to the data published by International Trade Administration in September 2020, the nutraceuticals market in India is expected to grow from an estimated USD 4 billion to USD 18 billion by the end of 2025.
Top Key Players & Market Share Insights:
The glucosamine market is highly competitive, with several large players and numerous small and medium-sized enterprises. These companies have strong research and development capabilities and a strong presence in the market through their extensive product portfolios and distribution networks. The market is characterized by intense competition, with companies focusing on expanding their product offerings and increasing their market share through mergers, acquisitions, and partnerships. The key players in the market include-
- Nutralife Health Products Inc.
- Blackmores Ltd.
- CAPTEK Softgel International Inc.
- Spectrum Chemicals
- Golden-Shell Pharmaceutical
- Foodchem International Corporation
- Health World Ltd.
- Glanbia plc.
- Cargill, Inc.
- Schiff Nutrition International, Inc.
Recent Industry Developments :
- In July 2023, Nestlé Purina PetCare, a manufacturer of pet food, announced the launch of a new supplement, targeting mobility in dogs. The new joint care supplement made up using glucosamine helps support mobility, healthy cartilage, and joints in dogs and puppies of all breeds and sizes.
- In October 2020, Nestle China announced the launch of a new milk powder in its functional foods product portfolio, which contains glucosamine for increasing bone density.
- In August 2020, JGL, a Croatia-based pharmaceutical company, announced the launch of a new food supplement Onaceron Forte for healthy joints. The product is based on glucosamine, which is used for normal cartilage and bone function.
Key Questions Answered in the Report
What was the market size of the glucosamine market in 2022? +
In 2022, the market size of glucosamine was USD 693.50 million
What will be the potential market valuation for the glucosamine market by 2030? +
In 2030, the market size of glucosamine will be expected to reach USD 1,082.65 million.
What are the key factors driving the growth of the glucosamine market? +
Increasing the use of glucosamine supplements to boost bone & joint health, in turn, propelling the glucosamine market growth.
What is the dominating segment in the glucosamine market by form? +
In 2022, the powder segment accounted for the highest market share of 35.10% in the overall glucosamine market.
Based on current market trends and future predictions, which geographical region will have the fastest impact on the glucosamine market's growth in the coming years? +
North America is expected to be the fastest-growing region in the market during the forecast period.
